Full-Time
Posted on 5/7/2026
Subscription-based digital health for fatty liver
$150k - $200k/yr
No H1B Sponsorship
New York, NY, USA
Remote
Remote work with occasional in-person collaboration in the New York area.
Salvo Health provides digital health services for metabolic liver diseases, mainly fatty liver disease. It runs a remote patient monitoring (RPM) platform that lets patients with conditions like MASLD and MASH stay connected with their care team via text, enabling real-time health management without frequent in-person visits. The service is delivered through a subscription model that includes personalized care plans and continuous access to clinicians, with potential reimbursements or partnership fees from payers and practices. How it differs from competitors is its focus on real-time, text-based communication and ongoing, personalized care for chronic liver and gut conditions via RPM, rather than one-off visits or generic digital programs. The company’s goal is to improve patient outcomes and satisfaction by making specialized liver-care more accessible, timely, and tailored to each patient’s needs.
Company Size
51-200
Company Stage
Series A
Total Funding
$28M
Headquarters
New York City, New York
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
People at Salvo Health who can refer or advise you
Health Insurance
Remote Work Options
Flexible Work Hours
Professional Development Budget
Salvo Health has raised $8.5 million in a Series A round led by ManchesterStory, City Light Capital and Threshold Ventures, following 800% revenue growth last year. The company provides wraparound support for independent gastroenterology practices rather than competing with them directly. The platform has signed 801 gastroenterologists, representing 16% of independent US practices. It offers patients access to registered dietitians, behavioural health specialists and nurses through AI-enabled continuous care that integrates with existing clinics. The hybrid model has delivered a 79% reduction in GI-related emergency room utilisation. Salvo addresses a fragmented market serving 100 million Americans with gastrointestinal issues, providing ongoing support for diet, stress management and medication adherence that independent practices typically cannot staff full-time.
Salvo Health raises $8.5M in Series A funding. Salvo Health, a New York-based provider of a virtual care platform specializing in gastrointestinal and metabolic health, raised $8.5m in Series A funding. The round was co-led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from new investors The Artemis Fund, Contour Venture Partners, Owl Capital, and Impact X Capital Partners, and existing investors Human Ventures, Torch Capital, Felicis Ventures, and Alumni Ventures. The company intends to use the funds to expand its engineering team for an AI-led roadmap and increase the national hiring of registered dietitians, behavioral health professionals, and nurses to meet rising patient demand. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, Salvo Health provides brick & mortar clinics with a continuous care platform that enables users to save time, increase revenue, and improve patient outcomes by offering direct access to a gut-focused care team. In 2025, the company has grown patients and revenue by 800% YoY and enterprise agreements with GI doctors by more than 1,000%. Salvo has also signed agreements with 801 GIs.
Salvo Health announces $4 million in new funding.
Salvo Health raised $4M in an extended Seed Prime round, following a $5M investment last year. The funds will expand its clinical team and virtual care platform across GI partner clinics with 700 physicians. The company, which launched in 2022 with $10.5M funding, has seen an 800% rise in patient volume and aims to grow revenue sixfold by year-end. New investor The Artemis Fund joined existing investors in this round.
Alumni Ventures invests in Salvo Health to revolutionize chronic condition management.